Gehen Sie mit der App Player FM offline!
41. Cell Free Systems w/ Michael Jewett - Professor @ Northwestern / Director @ NU Center for Synthetic Biology
Manage episode 322118524 series 3260755
Michael Jewett is the Charles Deering McCormick Professor of Teaching Excellence, a Professor of Chemical & Biological Engineering, & Co-Director of the Center for Synthetic Biology @ Northwestern University. He is also an Institute Fellow at the Northwestern Argonne Institute for Science & Engineering. Jewett’s lab seeks to re-conceptualize the way we engineer complex biological systems for compelling applications in medicine, materials, and energy by transforming biochemical engineering with synthetic biology. Dr. Jewett is the recipient of the NIH Pathway to Independence Award in 2009, David and Lucile Packard Fellowship in Science and Engineering in 2011, the DARPA Young Faculty Award in 2011, the Agilent Early Career Professor Award in 2011, the 3M non-tenured faculty grant in 2012, the Camille-Dreyfus Teacher-Scholar Award in 2015, the ACS Biochemical Technologies Division Young Investigator Award in 2017, and the Biochemical Engineering Journal Young Investigator Award in 2018.
w/ Special Guest Host: David Mace
David Mace is Co-founder & CEO @ SwiftScale Biologics, a life sciences startup based in San Francisco, California. SwiftScale Biologics accelerates time to market for protein drugs by turning a labor-intensive drug production scale-up challenge into a computational challenge. Previously David was an Entrepreneur in Residence at 8VC, where he focused on the intersection of biology & computer science. He is a graduate of the California Institute of Technology.
SwiftScale Biologics (@SwiftScaleBio) seeks to bring life-saving drugs to patients faster than previously possible. Specifically, SwiftScale uses cutting-edge cell-free and bacterial production platforms to rapidly produce protein therapeutics. SwiftScale’s technology is faster and cheaper than traditional manufacturing approaches, reducing time and cost to reach clinical trials and market. In Dec 2021, National Resilience acquired SwiftScale. Resilience is a technology focused manufacturing company dedicated to broadening access to complex medicines.
Thank you for listening!
BIOS (@BIOS_Community) unites a community of Life Science innovators dedicated to driving patient impact. Alix Ventures (@AlixVentures) is a San Francisco based venture capital firm supporting early stage Life Science startups engineering biology to create radical advances in human health.
64 Episoden
Manage episode 322118524 series 3260755
Michael Jewett is the Charles Deering McCormick Professor of Teaching Excellence, a Professor of Chemical & Biological Engineering, & Co-Director of the Center for Synthetic Biology @ Northwestern University. He is also an Institute Fellow at the Northwestern Argonne Institute for Science & Engineering. Jewett’s lab seeks to re-conceptualize the way we engineer complex biological systems for compelling applications in medicine, materials, and energy by transforming biochemical engineering with synthetic biology. Dr. Jewett is the recipient of the NIH Pathway to Independence Award in 2009, David and Lucile Packard Fellowship in Science and Engineering in 2011, the DARPA Young Faculty Award in 2011, the Agilent Early Career Professor Award in 2011, the 3M non-tenured faculty grant in 2012, the Camille-Dreyfus Teacher-Scholar Award in 2015, the ACS Biochemical Technologies Division Young Investigator Award in 2017, and the Biochemical Engineering Journal Young Investigator Award in 2018.
w/ Special Guest Host: David Mace
David Mace is Co-founder & CEO @ SwiftScale Biologics, a life sciences startup based in San Francisco, California. SwiftScale Biologics accelerates time to market for protein drugs by turning a labor-intensive drug production scale-up challenge into a computational challenge. Previously David was an Entrepreneur in Residence at 8VC, where he focused on the intersection of biology & computer science. He is a graduate of the California Institute of Technology.
SwiftScale Biologics (@SwiftScaleBio) seeks to bring life-saving drugs to patients faster than previously possible. Specifically, SwiftScale uses cutting-edge cell-free and bacterial production platforms to rapidly produce protein therapeutics. SwiftScale’s technology is faster and cheaper than traditional manufacturing approaches, reducing time and cost to reach clinical trials and market. In Dec 2021, National Resilience acquired SwiftScale. Resilience is a technology focused manufacturing company dedicated to broadening access to complex medicines.
Thank you for listening!
BIOS (@BIOS_Community) unites a community of Life Science innovators dedicated to driving patient impact. Alix Ventures (@AlixVentures) is a San Francisco based venture capital firm supporting early stage Life Science startups engineering biology to create radical advances in human health.
64 Episoden
Tüm bölümler
×Willkommen auf Player FM!
Player FM scannt gerade das Web nach Podcasts mit hoher Qualität, die du genießen kannst. Es ist die beste Podcast-App und funktioniert auf Android, iPhone und im Web. Melde dich an, um Abos geräteübergreifend zu synchronisieren.